Am­gen halts some drug dis­counts for safe­ty net hos­pi­tals as SCO­TUS takes on 340B case

Am­gen will soon be the 10th bio­phar­ma com­pa­ny to pull back on of­fer­ing drug dis­counts to con­tract phar­ma­cies of safe­ty-net hos­pi­tals un­der a fed­er­al pro­gram …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.